Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact
Priya Life Science Clinical trial register
Trackers› Clinical trials› Naples
Clinical trial register · Italy

Clinical Trials in Naples, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Italy and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 6793 matching records held by the registry are in this view. Synced 17 Nov 2026, 03:20 UTC
6793
Studies in scope
all four open statuses
4085
Recruiting now
open to new participants
1016
Lead sponsors
across recruiting studies
Top sites
Rome 1 Naples 1
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
AstraZeneca81 Hoffmann-La Roche46 Merck Sharp & Dohme LLC40 Bristol-Myers Squibb36 National Cancer Institute, Naples36 Federico II University33 AbbVie26 Eli Lilly and Company22 Janssen Research & Development, LLC21 Novartis Pharmaceuticals20 Sanofi18 Pfizer17 GlaxoSmithKline17 Boehringer Ingelheim15 Daiichi Sankyo15 University of Campania Luigi Vanvitelli13 Incyte Corporation12 Novo Nordisk A/S11 Takeda9 Regeneron Pharmaceuticals8 Alexion Pharmaceuticals, Inc.8 Amgen8 Bayer7 Celgene7 Exelixis7 argenx7 Istituto Giannina Gaslini6 EMD Serono Research & Development Institute, Inc.6 Philogen S.p.A.6 European Organisation for Research and Treatment of Cancer - EORTC6 BioNTech SE6 IRCCS Azienda Ospedaliero-Universitaria di Bologna6 Ipsen5 IRCCS SYNLAB SDN5 Fondazione Policlinico Universitario Agostino Gemelli IRCCS4 BeOne Medicines4 Genmab4 Revolution Medicines, Inc.4 Tesaro, Inc.4 Gilead Sciences4 Meyer Children's Hospital IRCCS4 Immunocore Ltd4 Agios Pharmaceuticals, Inc.4 Ionis Pharmaceuticals, Inc.3 Stemline Therapeutics, Inc.3 Istituti Clinici Scientifici Maugeri SpA3 Fondazione Italiana Linfomi - ETS3 Immunovant Sciences GmbH3 University of Oxford3 Dr. Inge Winter3 Karyopharm Therapeutics Inc3 Azienda USL Reggio Emilia - IRCCS3 Fondazione Melanoma Onlus3 Università Vita-Salute San Raffaele3 Swedish Orphan Biovitrum3 Boston Scientific Corporation3 Alfasigma S.p.A.3 Cardarelli Hospital3 Alnylam Pharmaceuticals3 Seagen, a wholly owned subsidiary of Pfizer3 Biohaven Therapeutics Ltd.2 Mirati Therapeutics Inc.2 Astellas Pharma Global Development, Inc.2 Fondazione SISA (Societa Italiana per lo Studio della Arteriosclerosi)2 ISTITUTO FARMOCHIMICO FITOTERAPICO: EPO SRL2 Jazz Pharmaceuticals2 University Hospital, Basel, Switzerland2 Ataxia Study Group2 IDEAYA Biosciences2 Biogen2 Azienda Ospedaliera "Sant'Andrea"2 Pierre Fabre Medicament2 Amicus Therapeutics2 IRCCS San Raffaele2 CUTISS AG2 K-Group, Beta, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals, Inc2 European Institute of Oncology2 Istituto Clinico Humanitas2 CSL Behring2 Insel Gruppe AG, University Hospital Bern2 Cytokinetics2 Medipol University2 RECORDATI GROUP2 Centro Cardiologico Monzino2 Janssen-Cilag Ltd.2 Neurocrine Biosciences2 ACADIA Pharmaceuticals Inc.2 Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta2 UNICANCER2 Fidia Farmaceutici s.p.a.2 Devintec Sagl2 Vertex Pharmaceuticals Incorporated2 Crinetics Pharmaceuticals Inc.2 Deciphera Pharmaceuticals, LLC2 University Hospital of Ferrara2 Azienda Ospedaliero-Universitaria di Modena2 Abbott Medical Devices2 Centro di Riferimento Oncologico - Aviano2 Womed1 Università degli Studi di Ferrara1 Pulmovant, Inc.1 Kura Oncology, Inc.1 Calluna Pharma AS1 Biosense Webster, Inc.1 Weill Medical College of Cornell University1 M.A. Med Alliance S.A.1 University of Bari1 BioMarin Pharmaceutical1 Medtronic MiniMed, Inc.1 Genentech, Inc.1 University of Pisa1 NeuroDerm Ltd.1 MedSIR1 Servier Affaires Médicales1 Assembly Biosciences1 Day One Biopharmaceuticals, Inc.1 University Hospital, Ghent1 Loxo Oncology, Inc.1 Arcus Biosciences, Inc.1 Copenhagen University Hospital, Rigshospitalet1 Celcuity Inc1 University of Naples1 Manuel Monreal1 BicycleTx Limited1 Fondazione ICONA1 Inventiva Pharma1 Napo Therapeutics, S.p.A.1 Giovanni Di Perri1 Istituto Superiore di Sanità1 Chiesi Farmaceutici S.p.A.1 Francesco De Cobelli1 ModernaTX, Inc.1 Almirall, S.A.1 Fondazione Valter Longo1 Ascendis Pharma A/S1 MediWound Ltd1 Verastem, Inc.1 D3 Bio (Wuxi) Co., Ltd1 TransThera Sciences (Nanjing), Inc.1 Lexeo Therapeutics1 Hedera Dx SA1 Sorveglianza Epidemiologica Infezioni Fungine Emopatie Maligne1 Istituto Ortopedico Rizzoli1 NewAmsterdam Pharma1 University College Cork1 EndoCore Lab s.r.l.1 Clinica Mediterranea1 Tourmaline Bio, Inc., a Novartis Company1 Karolinska Institutet1 Fundación EPIC1 Chiesi Italia1 Medtronic Cardiovascular1 Marco Emilio Bianchi1 Dianthus Therapeutics1 Vor Biopharma1 Research Maatschap Cardiologen Rotterdam Zuid1 Azienda Ospedaliero-Universitaria Careggi1 Zydus Therapeutics Inc.1 Istituto Oncologico Veneto IRCCS1 FROM- Fondazione per la Ricerca Ospedale di Bergamo- ETS1 Prilenia1 Advanced Accelerator Applications1 Lionhealth Srl Società Benefit1 Mayo Clinic1 Phenox GmbH1 Synbalance S.r.l.1 CoreAalst BV1 Aristotle University Of Thessaloniki1 Airway Therapeutics, Inc.1 UCB Biopharma SRL1 Olema Oncology, Inc.1 Santa Chiara Hospital1 Vedanta Biosciences, Inc.1 SpringWorks Therapeutics, Inc., a healthcare company of Merck KGaA, Darmstadt, Germany1 Fore Biotherapeutics1 Kedrion S.p.A.1 Pharvaris Netherlands B.V.1 NovoCure GmbH1 Nuvation Bio Inc.1 ROELMI HPC1 Società Italiana Talassemie ed Emoglobinopatie1 Shanghai Junshi Bioscience Co., Ltd.1 AAVantgarde Bio Srl1 Assistance Publique - Hôpitaux de Paris1 University of Turin, Italy1 Lexicon Pharmaceuticals1 Health and Happiness Research Limited1 IFOM ETS - The AIRC Institute of Molecular Oncology1 H. Lundbeck A/S1 Pasquale Arpaia1 Prof. Dr. Matthis Synofzik1 Celldex Therapeutics1 NMD Pharma A/S1 Acrivon Therapeutics1 VisionCare, Inc.1 Incyte Biosciences International Sàrl1 Praxis Precision Medicines1 Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)1 Princess Maxima Center for Pediatric Oncology1 DualityBio Inc.1 OSE Immunotherapeutics1 Fondazione Oncotech1 Santen SAS1 medac GmbH1 Enterome1 Iperboreal Pharma Srl1 PharmaMar1 HiFiBiO Therapeutics1 University Hospital, Tours1 Insmed Incorporated1 GUIDO CAMANNI1 Janssen Pharmaceutica N.V., Belgium1 Imbria Pharmaceuticals, Inc.1 AGO Study Group1 ETOP IBCSG Partners Foundation1 Boston University1 MicroPort CRM1 Bicara Therapeutics1 Valerio Nardone1 Mario Negri Institute for Pharmacological Research1 Mastelli S.r.l1 OncoVerity, Inc.1 Maddalena Casale1 Mirum Pharmaceuticals, Inc.1 W.L.Gore & Associates1 LeonaBio1 Implantica CE Reflux Ltd.1 iOnctura1 Careggi Hospital1 Bold Therapeutics, Inc.1 Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia1 CHDI Foundation, Inc.1 Imperial College London1 Regina Elena Cancer Institute1 Institut de Recherches Internationales Servier1 Shanghai Henlius Biotech1 Hospital Universitario 12 de Octubre1 Debiopharm International SA1 University of Leeds1 Gossamer Bio USA, Inc.1 University of Milan1 Akcea Therapeutics1 Niguarda Hospital1 Monaldi Hospital1 University of Milano Bicocca1 C4 Therapeutics, Inc.1 Spark Therapeutics, Inc.1 Greenwich LifeSciences, Inc.1 Fondazione Evidence per Attività e Ricerche Cardiovascolari ONLUS1 Prof. Valérie Mc Lin1 Société des Produits Nestlé (SPN)1 Ultragenyx Pharmaceutical Inc1 Genethon1 Inhibrx Biosciences, Inc1 Nordic Lymphoma Group1 Epizyme, Inc.1 MeiraGTx Ocular UK Ltd1 NVT GmbH1 Aesculap AG1 Norgine1 Valo Therapeutics Oy1 Royal College of Surgeons, Ireland1 Iovance Biotherapeutics, Inc.1 Ono Pharmaceutical Co., Ltd.1 Ascentage Pharma Group Inc.1 Elixir Medical Corporation1 ARCAGY/ GINECO GROUP1 Impulse Dynamics1 Kumquat Biosciences Inc.1 University of Padova1 Società Italiana di Allergologia, Asma e Immunologia Clinica1 A.O.U. Città della Salute e della Scienza1 GT Metabolic Solutions, Inc.1 Casa di Cura Dott. Pederzoli1 Zenas BioPharma (USA), LLC1 IO Biotech1 Bioprojet1 Fondazione Policlinico Universitario Campus Bio-Medico1 Gruppo Italiano Trapianto di Midollo Osseo1 Xenothera SAS1 OncoC4, Inc.1 IRCCS Policlinico S. Donato1 Immutep S.A.S.1 Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company1 Raffaele Marfella1 Galderma R&D1 Azienda Ospedaliero-Universitaria di Parma1 Anika Therapeutics, Inc.1 Microbiotica Ltd1 Neuron23 Inc.1 St. Anna Kinderkrebsforschung1 Istituto Auxologico Italiano1 MoonLake Immunotherapeutics AG1 Vividion Therapeutics, Inc.1 Weizmann Institute of Science1 Octapharma1 Mario Musella MD1 Eisai Inc.1 MSD Italia S.r.l.1 ProQR Therapeutics1 Translumina Therapeutics Pvt Ltd.1 Adamas Biotech S.r.l.1 Fondazione IRCCS Policlinico San Matteo di Pavia1 Xynomic Pharmaceuticals, Inc.1 Servier Bio-Innovation LLC1 Iambic Therapeutics, Inc1 Esteve Pharmaceuticals, S.A.1 Otsuka Pharmaceutical Development & Commercialization, Inc.1 Bioverativ, a Sanofi company1 Gruppo Oncologico del Nord-Ovest1 UCB BIOSCIENCES, Inc.1 Axon srl1 United Pharmaceuticals1 Fondazione IRCCS Istituto Nazionale dei Tumori, Milano1 BioGaia AB1 Avalyn Pharma Inc.1 pharmaand GmbH1 Intergruppo Melanoma Italiano1 Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS1 National Eye Institute (NEI)1 Emalex Biosciences Inc.1 Cardiac Dimensions, Inc.1 Corcym S.r.l1 Ivy Brain Tumor Center1 PMV Pharmaceuticals, Inc1 Exact Sciences Corporation1 Corcept Therapeutics1 Gemelli Molise Hospital1 HUYABIO International, LLC.1 Solstice Oncology, Inc.1 MedImmune LLC1 enGene, Inc.1 SecuraBio1 Clear sponsor filter
Site location
Rome1 Naples1
All 2 locations
Target enrolment
to

Trials with a site in Naples

1 of 6793 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Italy
Start
Recruiting
Impulse Dynamics
Observational
200
Rome, Naples
2025-02-01
Rows per page Showing 1–1 of 1
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with an Italian investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 17 November 2026. https://priyalifescience.com/clinical-trials-italy/city/naples

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Italy and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 6,793 studies in total at the last sync on 17 Nov 2026, 03:20 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 1 of those studies with a site in Naples that also match the filters currently applied.

How many clinical trials are recruiting in Naples?

1 of the 1 studies on this page are recruiting new participants as of the 17 Nov 2026, 03:20 UTC sync. A further 0 have not yet opened recruitment, 0 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Naples), 1 studies
PhaseStudiesRecruitingShare
Observational11100%

Most active sponsors

Lead sponsors with the most studies (Naples)
Lead sponsorStudiesRecruiting
Impulse Dynamics11
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.